4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State

Systemic inflammation has been linked to suppressed CYP3A(4) activity. We determined 4β‐hydroxycholesterol (4βOHC), an endogenous CYP3A4 metabolite, in patients with rheumatoid arthritis (RA) before and after treatment with biological disease‐modifying antirheumatic drugs (bDMARDs). The 4βOHC was co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollmann, BM, Syversen, SW, Lie, E, Gjestad, C, Mehus, LL, Olsen, IC, Molden, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351010/
https://www.ncbi.nlm.nih.gov/pubmed/27991741
http://dx.doi.org/10.1111/cts.12431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351010/
https://www.ncbi.nlm.nih.gov/pubmed/27991741
http://dx.doi.org/10.1111/cts.12431

Ejemplares similares